Codexis Research Development from 2010 to 2026

CDXS Stock  USD 1.61  0.00  0.00%   
Codexis' Research Development is increasing over recent years with slightly volatile volatility. It is projected to reach approximately 46.4 M this year. From 2010 to 2026, Codexis Research Development regression analysis produced a arithmetic mean of 41,293,448 . alongside coefficient of variation of 42.17 . View All Fundamentals
 
Research Development  
 First Reported
2006-12-31
 Previous Quarter
1.8 M
 Current Value
33.1 M
 Quarterly Volatility
5.4 M
Macro event markers
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
This statements view for Codexis organizes long-term performance signals with capital structure context. This context pairs drivers like Depreciation And Amortization of 4.5 M, Interest Expense of 2.6 M or Selling General Administrative of 36.4 M and ratios such as Price To Sales Ratio of 1.92, Dividend Yield of 0.0 or PTB Ratio of 3.97 with Codexis Valuation and Volatility views.
  
Build AI portfolio with Codexis Stock
Codexis Correlation provides competitor comparison context for Codexis. This adds peer-relative context.
For information on how to trade Codexis Stock refer to our How to Trade Codexis Stock guide.
The evolution of Research Development for Codexis provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Codexis compares to historical norms and industry peers.

Latest Codexis' Research Development Growth Pattern

Below is the plot of the Research Development of Codexis over the last few years. It is Codexis' Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Codexis' overall financial position and show how it may be relating to other accounts over time.
Research Development10 Years Trend
Slightly volatile
   Research Development   
       Timeline  

Codexis Research Development Regression Statistics

Arithmetic Mean 41,293,448
Geometric Mean 37,814,522
Coefficient Of Variation 42.17
Mean Deviation 14,390,304
Median 44,185,000
Standard Deviation 17,411,530
Sample Variance303.2T
Range62.8M
R-Value 0.41
Mean Square Error269.7T
R-Squared 0.17
Significance 0.10
Slope 1,404,250
Total Sum of Squares4850.6T

Codexis Research Development History

202646.4 M
202544.4 M
202446.3 M
202358.9 M
202280.1 M
202155.9 M
202044.2 M

Stock Overview, Methodology & Data Sources

Codexis, Inc. discovers, develops, and sells enzymes and other proteins. The company was incorporated in 2002 and is headquartered in Redwood City, California. Codexis operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 261 people. The stock overview for Codexis summarizes business drivers, financial profile, and market behavior. The company is positioned within Life Sciences Tools & Services, Pharmaceuticals, Biotechnology & Life Sciences, Health Care. Current metrics include P/B of 3.77, profit margin of -62.47%. Codexis has a market cap of 145.42 M, ROE of -74.88%.

Methodology

Unless otherwise specified, financial data for Codexis is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Codexis (USA Stocks:CDXS) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: Inputs rely on public filings and market reference sources and institutional disclosures from U.S. Securities and Exchange Commission (SEC) via EDGAR. Publication cadence can introduce timing differences. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.

Analyst Sources

Codexis may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.

This content is curated and reviewed by:

Ellen Johnson - Member of Macroaxis Editorial Board
Last reviewed on February 19th, 2026

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Codexis Stock Analysis

Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Commodity Directory
Find actively traded commodities issued by global exchanges
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
CEOs Directory
Screen CEOs from public companies around the world
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine